Biblio Discovery — Demo Discovery Service

8 results for "Sumit Raybardhan"

Showing 1–8 · 0.97 seconds · RSS

  1. Journal Article

    Using a behavioural framework to optimize antibiotic prescribing by family medicine residents

    Samantha Moe; Tiffany Kan; Charlene Soobiah et al.

    MedEdPublish, Vol. 10 No. 1 · 2021 · English · DOAJ Scopus

    Background and objectives: Overprescribing of antibiotics in primary care is a prominent concern in the context of increasing antimicrobial resistance worldwide. Medical trainees are a key group to deliver thoughtful antimicrobial stewardship training. This study examined the factors influencing…

  2. Journal Article

    Institutional spillover effects of antimicrobial use on antimicrobial resistance and Clostridioides difficile: a systematic review

    Sumit Raybardhan; Bradley Langford; Russell Forrest et al.

    Antimicrobial Stewardship & Healthcare Epidemiology, Vol. 6 · 2026 · English · DOAJ Scopus

    Abstract Objective: To synthesize evidence on institutional spillover effects of antimicrobial use (AMU) on antimicrobial resistance (AMR) and Clostridioides difficile infections on individuals without direct antimicrobial exposure. Design: Systematic review. Methods: Three databases were searched…

  3. Journal Article

    Usefulness of Previous Methicillin-resistant Staphylococcus aureus Screening Results in Guiding Empirical Therapy for S Aureus Bacteremia

    Anthony D Bai; Lisa Burry; Adrienne Showler et al.

    Canadian Journal of Infectious Diseases and Medical Microbiology, Vol. 26 No. 4 · 2015 · English · DOAJ Scopus

    BACKGROUND: Staphylococcus aureus bacteremia (SAB) is an important infection. Methicillin-resistant S aureus (MRSA) screening is performed on hospitalized patients for infection control purposes.

  4. Journal Article

    Ivermectin treatment for Strongyloides infection in patients with COVID-19

    Elizabeth Leung; Sumit Raybardhan; Christopher Graham et al.

    Canada Communicable Disease Report, Vol. 47 No. 78 · 2021 · French · DOAJ

    Ivermectin, an antiparasitic agent, is not recommended for prophylaxis or treatment of coronavirus disease 2019 (COVID-19). Inappropriate use of ivermectin for treatment of COVID-19 may make it less available for patients with serious parasitic infections who could benefit from its use and worsen…

  5. Journal Article

    Traitement à l’ivermectine pour l’infection à Strongyloides chez les patients atteints de COVID-19

    Elizabeth Leung; Sumit Raybardhan; Christopher Graham et al.

    Canada Communicable Disease Report, Vol. 47 No. 78 · 2021 · French · DOAJ

    L’ivermectine, un agent antiparasitaire, n’est pas recommandé pour la prophylaxie ou le traitement de la maladie à coronavirus 2019 (COVID-19). L’utilisation inappropriée de l’ivermectine pour le traitement de la COVID-19 peut en diminuer la disponibilité pour les patients atteints d’infections…

  6. Journal Article

    Antimicrobial stewardship: coming to a community pharmacy near you? A cross-sectional study to understand the perspectives of pharmacists, prescribers and the public

    Bradley J. Langford; Shankavi Vigneswaran; Nick Daneman et al.

    Antimicrobial Stewardship & Healthcare Epidemiology, Vol. 6 · 2026 · English · DOAJ Scopus

    This survey of the public, pharmacists, and other healthcare professionals identified factors affecting implementation of antibiotic stewardship in Canadian community pharmacies. Lack of support from non-pharmacist healthcare providers and pharmacy leadership were common barriers. Facilitators…